TY - JOUR
T1 - A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients
AU - Sato, Toshihiko
AU - Kondo, Haruhiko
AU - Watanabe, Atsushi
AU - Nakajima, Jun
AU - Niwa, Hiroshi
AU - Horio, Hirotoshi
AU - Okami, Jiro
AU - Okumura, Norihito
AU - Sugio, Kenji
AU - Teramukai, Satoshi
AU - Kishi, Kazuma
AU - Ebina, Masahito
AU - Sugiyama, Yukihiko
AU - Kondo, Takashi
AU - Date, Hiroshi
N1 - Funding Information:
This work was supported by the Japan Intractable Disease Research Foundation of Japanese Ministry of Health and Welfare and the Japanese Association for Chest Surgery. No involvement of the funding resources in the design or conduct of this investigator-initiated study, data collection, management, analysis, or interpretation of the data, preparation, review, and approval of the manuscript, or decision to submit the manuscript. The authors had full control of the study design, methods, outcome variables, and results, data analysis, and manuscript production.
Publisher Copyright:
© 2014, The Japanese Association for Thoracic Surgery.
PY - 2015/3
Y1 - 2015/3
N2 - Objective: Lung cancer patients with interstitial lung diseases (ILDs) who have undergone pulmonary resection often develop acute exacerbation of interstitial pneumonia (AE) in the post-operative period. To predict who is at high risk of AE, we propose a scoring system that evaluates the risk of AE in lung cancer patients with ILDs.Methods: We derived a score for 30-day risk of AE onset after pulmonary resection in lung cancer patients with ILDs (n = 1,022; outcome: risk of AE) based on seven risk factors for AE that were identified in a previous retrospective multi-institutional cohort study. A logistic regression model was employed to develop a risk prediction model for AE.Results: A risk score (RS) was derived: 5 × (history of AE) + 4 × (surgical procedures) + 4 × (UIP appearance in CT scan) + 3 × (male sex) + 3 × (preoperative steroid use) + 2 × (elevated serum sialylated carbohydrate antigen, KL-6 level) + 1 × (low vital capacity). The RS was shown to be moderately discriminatory with a c-index of 0.709 and accurate with the Hosmer–Lemeshow goodness-of-fit test (p = 0.907). The patients were classified into three groups: low risk (RS: 0–10; predicted probability <0.1; n = 439), intermediate risk (RS: 11–14; predicted probability 0.1–0.25; n = 559), and high risk (RS: 15–22; predicted probability >0.25; n = 24).Conclusion: Although further validation and refinement are needed, the risk score can be used in routine clinical practice to identify high risk individuals and to select proper treatment strategies.
AB - Objective: Lung cancer patients with interstitial lung diseases (ILDs) who have undergone pulmonary resection often develop acute exacerbation of interstitial pneumonia (AE) in the post-operative period. To predict who is at high risk of AE, we propose a scoring system that evaluates the risk of AE in lung cancer patients with ILDs.Methods: We derived a score for 30-day risk of AE onset after pulmonary resection in lung cancer patients with ILDs (n = 1,022; outcome: risk of AE) based on seven risk factors for AE that were identified in a previous retrospective multi-institutional cohort study. A logistic regression model was employed to develop a risk prediction model for AE.Results: A risk score (RS) was derived: 5 × (history of AE) + 4 × (surgical procedures) + 4 × (UIP appearance in CT scan) + 3 × (male sex) + 3 × (preoperative steroid use) + 2 × (elevated serum sialylated carbohydrate antigen, KL-6 level) + 1 × (low vital capacity). The RS was shown to be moderately discriminatory with a c-index of 0.709 and accurate with the Hosmer–Lemeshow goodness-of-fit test (p = 0.907). The patients were classified into three groups: low risk (RS: 0–10; predicted probability <0.1; n = 439), intermediate risk (RS: 11–14; predicted probability 0.1–0.25; n = 559), and high risk (RS: 15–22; predicted probability >0.25; n = 24).Conclusion: Although further validation and refinement are needed, the risk score can be used in routine clinical practice to identify high risk individuals and to select proper treatment strategies.
KW - Interstitial pneumonia
KW - Lung cancer surgery
KW - Post-operative morbidity
UR - http://www.scopus.com/inward/record.url?scp=84924333277&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84924333277&partnerID=8YFLogxK
U2 - 10.1007/s11748-014-0487-6
DO - 10.1007/s11748-014-0487-6
M3 - Article
AN - SCOPUS:84924333277
VL - 63
SP - 164
EP - 172
JO - General Thoracic and Cardiovascular Surgery
JF - General Thoracic and Cardiovascular Surgery
SN - 1863-6705
IS - 3
ER -